Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
Microsoft
MSFT
|
+$447M |
| 2 |
Bath & Body Works
BBWI
|
+$338M |
| 3 |
Home Depot
HD
|
+$277M |
| 4 |
GE Aerospace
GE
|
+$267M |
| 5 |
Palo Alto Networks
PANW
|
+$236M |
Top Sells
| 1 |
LNKD
LinkedIn Corporation
LNKD
|
+$714M |
| 2 |
ARMH
ARM HOLDINGS PLC ADS
ARMH
|
+$414M |
| 3 |
Citigroup
C
|
+$376M |
| 4 |
Sherwin-Williams
SHW
|
+$292M |
| 5 |
Starbucks
SBUX
|
+$266M |
Sector Composition
| 1 | Consumer Discretionary | 20.49% |
| 2 | Healthcare | 16.68% |
| 3 | Communication Services | 14.23% |
| 4 | Technology | 14.03% |
| 5 | Financials | 9.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ETP
451
DELISTED
Energy Transfer Partners, L.P.
ETP
| $10.6M | 0.01% |
421,005
+162,422
| +63% | +$4.07M |
|
452
Graco
GGG
$14B
| $10.4M | 0.01% |
+370,623
| New | +$10.4M |
|
|
ICD
453
DELISTED
Independence Contract Drilling, Inc.
ICD
| $10.3M | 0.01% |
108,136
-16,767
| -13% | -$1.6M |
|
454
Assembly Biosciences
ASMB
$178M
| $10.2M | 0.01% |
169,959
+1,136
| +0.7% | +$68.4K |
|
455
Natera
NTRA
$24.2B
| $10M | 0.01% |
1,051,463
-49,399
| -4% | -$470K |
|
456
Marcus & Millichap
MMI
$1.27B
| $9.87M | 0.01% |
388,898
-40,841
| -10% | -$1.04M |
|
457
Standard BioTools
LAB
$489M
| $9.7M | 0.01% |
1,201,393
+434,249
| +57% | +$3.5M |
|
|
BWP
458
DELISTED
Boardwalk Pipeline Partners
BWP
| $9.58M | 0.01% |
649,646
+220,563
| +51% | +$3.25M |
|
|
AGTC
459
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $9.57M | 0.01% |
684,440
+6,830
| +1% | +$95.5K |
|
|
EEP
460
DELISTED
Enbridge Energy Partners
EEP
| $9.26M | 0.01% |
505,696
+232,849
| +85% | +$4.27M |
|
|
FENX
461
DELISTED
Fenix Parts, Inc.
FENX
| $9.03M | 0.01% |
1,963,187
+89,689
| +5% | +$413K |
|
|
PSXP
462
DELISTED
PHILLIPS 66 PARTNERS LP
PSXP
| $8.44M | 0.01% |
134,914
+41,255
| +44% | +$2.58M |
|
|
CMO
463
DELISTED
Capstead Mortgage Corp.
CMO
| $8.44M | 0.01% |
853,597
-1,343,313
| -61% | -$13.3M |
|
|
KA
464
DELISTED
Kineta, Inc. Common Stock
KA
| $8.06M | 0.01% |
+5,972
| New | +$8.06M |
|
|
GNMX
465
DELISTED
Aevi Genomic Medicine, Inc.
GNMX
| $7.75M | 0.01% |
1,761,044
+12,932
| +0.7% | +$56.9K |
|
466
Salarius Pharmaceuticals
SLRX
$2.36M
| $7.57M | 0.01% |
9
| – | – |
|
|
AEUA
467
DELISTED
Anadarko Petroleum Corporation
AEUA
| $7.23M | 0.01% |
210,621
+19,739
| +10% | +$678K |
|
|
RMP
468
DELISTED
Rice Midstream Partners LP
RMP
| $7.19M | 0.01% |
482,668
+76,781
| +19% | +$1.14M |
|
|
B
469
DELISTED
Barnes Group Inc.
B
| $7.08M | 0.01% |
202,047
-243,587
| -55% | -$8.53M |
|
|
ATHN
470
DELISTED
Athenahealth, Inc.
ATHN
| $7.05M | 0.01% |
+50,810
| New | +$7.05M |
|
|
EPRS
471
DELISTED
EPIRUS BIOPHARMACEUTICALS INC COM
EPRS
| $7.03M | 0.01% |
2,613,159
+15,291
| +0.6% | +$41.1K |
|
472
LendingClub
LC
$1.89B
| $6.81M | 0.01% |
164,018
+1,144
| +0.7% | +$47.5K |
|
473
Corvus Pharmaceuticals
CRVS
$460M
| $6.58M | 0.01% |
+464,132
| New | +$6.58M |
|
|
CMRX
474
DELISTED
Chimerix, Inc.
CMRX
| $6.56M | 0.01% |
1,284,070
+10,291
| +0.8% | +$52.6K |
|
|
ACOR
475
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $6.4M | 0.01% |
2,018
-748
| -27% | -$2.37M |
|